Updated Oct. 1 – A blood test called “epitope mapping” accurately predicted peanut allergy 93 percent of the time, a… Read more »
Peanut & Tree Nut
Strong Results for SLIT Therapy Seen in Peanut-Allergic Toddlers
In a small study, sublingual immunotherapy (SLIT) was effective in desensitizing peanut-allergic toddlers, allowing 74 percent to consume 4,443 milligrams… Read more »
Allergy News: EpiPen Class Action Can Proceed; DBV Hopeful on Patch
Mylan Loses Bid to Dismiss Lawsuit A U.S. district judge has ruled that a class action lawsuit against Mylan Inc.,… Read more »
FARE Retreat: Experts Explore Food Allergy Treatment, Testing
“Science is showing us the path to a future in which new therapeutic options may provide both solutions as well… Read more »
FDA Turns Down Viaskin Peanut Patch Approval Bid
The FDA says it won’t approve DBV Technologies’ Viaskin Peanut, the novel skin patch allergy desensitization treatment, at least not… Read more »
Palforzia OIT Study Sees Maturing of Immune System Over Time
A new study finds encouraging results for those considering the first FDA-approved peanut allergy immunotherapy. It reveals that clinical trial… Read more »
Groundbreaking Study Finds Peanut Allergy Likely Starts In The Gut
Scientists have long known that when it comes to allergic reactions, the IgE antibody is the main culprit. But a… Read more »
Allergists See Palforzia as Start to New Era of Food Allergy Therapies
Allergists that Allergic Living contacted are excited about the FDA’s approval of the first-ever therapy for a food allergy. They… Read more »
Study Shows High Costs and Burden of Peanut Allergy
A study of a large U.S. health insurer database reveals the high dollar and health costs for those living with… Read more »
FDA Approves Aimmune’s Palforzia OIT, Coming Soon to Allergist Clinics
The Food and Drug Administration on Jan. 31 approved Palforzia, Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for peanut allergy in… Read more »